Fundraising Fox

Infinity Bio

Baltimore, US · Founded 2023 · 3 known investors

infinitybio.com ↗

Infinity Bio develops molecular indexing technology to decode antibody-antigen binding interactions for research and therapeutic applications in the biotech field.

Biotechin /infinity-bio-inc

Founders & leadership

BL
Benjamin LarmanExecutive Officer, Director
JM
Joy M NassifExecutive Officer, Director
JN
Joy NassifExecutive Officer, Director
MH
Matthew HellauerDirector
HS
Herman ScholtzDirector
CP
Caroline PopperDirector

Investors · 3

Illumina VenturesFoster City
TCP Venture CapitalBaltimore
PTX CapitalreportedBaltimore

Reported raises · per SEC filings

Form D private placements
▶$5MraisedAug 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill CampbellDirector
  • Caroline PopperDirector
  • Malek FahemDirector
  • H. Benjamin LarmanExecutive Officer, Director
  • Herman ScholtzDirector
  • Matthew HellauerDirector
  • Joy NassifExecutive Officer, Director
Offering amount
$7M
Amount sold
$5M
First sale
Jun 2025
Incorporated
Corporation, United States, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HellauerDirector
  • Benjamin LarmanExecutive Officer, Director
  • Herman ScholtzDirector
  • Joy M NassifExecutive Officer, Director
  • Caroline PopperDirector
Offering amount
$5M
Amount sold
$2M
First sale
Feb 2025
Incorporated
Corporation, United States, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJun 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Herman ScholtzDirector
  • Joy NassifExecutive Officer, Director
  • Matthew HellauerDirector
  • Benjamin LarmanExecutive Officer, Director
  • Caroline PopperDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Jun 2023
Incorporated
Corporation, United States, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.